CD40LG and Lyme disease: The antigens BBA65, BBA70, and BBA73 were selected for IgM serum immunoreactivity evaluation in early Lyme disease patients together with the three antigens currently used in IgM second-tier immunoblotting, OspC, BmpA, and FlaB.